Ranjith Chandrasena, MD
Original Research
Quetiapine XR in Comorbid Depression and Anxiety
March 21, 2022
Quetiapine is often used off-label for anxiety and as an augmentation agent in treatment-resistant depression. This study evaluated the efficacy and tolerability of quetiapine in augmenting first-line antidepressants for...
Letter to the Editor
Nabilone and Dementia-Associated Sexual Inhibition
February 19, 2015
A variety of pharmacologic interventions have been utilized to manage behavioral and psychological symptoms of dementia. Is nabilone an effective treatment option for agitation and sexual disinhibition, which are...